Active substanceOctreotideOctreotide Similar drugsTo uncover Genfastat® solution in / in PC Genfa Medica S.A. Switzerland Octreotide solution in / in PC FARM-SYNTHESIS, CJSC Russia Octreotide solution in / in PC NATIVA, LLC Russia Octreotide solution in / in PC F-SYNTHESIS, CJSC Russia Octreotide solution in / in PC F-SYNTHESIS, CJSC Russia Octreotide Kabi solution in / in PC Fresenius Kabi Deutschland GmbH Germany Octreotide San solution in / in PC San Pharmaceutical Industries Co., Ltd. India Octreotide-Actavis solution d / infusion PC Actavis PTS ehf Group Iceland Octreotide Depot lyophilizate w / m FARM-SYNTHESIS, CJSC Russia Octreotide-long FS lyophilizate w / m NATIVA, LLC Russia Octretex® solution d / infusion PC FarmSirma Soteks, ZAO Russia Sandostatin® solution in / in PC Novartis Pharma AG Switzerland Sandostatin® Lar powder w / m Novartis Pharma AG Switzerland SERAKSTAL solution d / infusion PC Dosage form: & nbspsolution for intravenous and subcutaneous administration Pharmacotherapeutic group:Somatostatin analogue synthetic ATX: & nbspH.01.C.B.02 Octreotide Form release / dosage:Solution for intravenous and subcutaneous administration, 50, 100 μg / ml. Packaging:5, 10 ampoules per pack of cardboard. Storage conditions:In the dark place at a temperature of 8 to 25 ° C. Shelf life:5 years. Terms of leave from pharmacies:On prescription Registration number:P N002374 / 01 Date of registration:21.04.2008 / 07.07.2016 Expiration Date:Unlimited The owner of the registration certificate:F-SYNTHESIS, CJSC F-SYNTHESIS, CJSC Russia Manufacturer: & nbspF-SYNTHESIS, CJSC Russia Information update date: & nbsp26.05.2017 Illustrated instructions × Illustrated instructions Instructions